v3.26.1
Statement of Changes in Shareholders' Deficit - 6 months ended Dec. 31, 2025 - USD ($)
Total
Common Class A [Member]
Common Class B [Member]
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance, shares at Jul. 10, 2025       0      
Beginning balance, Amount at Jul. 10, 2025       $ 0      
Issuance of Class B ordinary shares to Sponsor, Shares [1],[2]         14,785,714    
Issuance of Class B ordinary shares to Sponsor, Value $ 25,000       $ 1,478 $ 23,522  
Accretion for Class A ordinary shares to redemption amount (14,493,808) $ (14,493,808)       (1,770,828) $ (12,722,980)
Sale of 175,000 Private Placement Shares, Shares       175,000      
Sale of 175,000 Private Placement Shares, Value 1,750,000     $ 18   1,749,982  
Allocated value of transaction costs to Private Placement Shares (2,676)         $ (2,676)  
Net loss (7,197,255) $ (4,123,633) $ (3,073,622)       (7,197,255)
Ending balance, shares at Dec. 31, 2025       175,000 14,785,714 [1],[2]    
Ending Balance, Amount at Dec. 31, 2025 $ (19,918,739)     $ 18 $ 1,478   $ (19,920,235)
[1] Includes 1,928,571 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 29, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,928,571 founder shares are no longer subject to forfeiture (see Note 5).
[2] On September 25, 2025, the Company issued an additional 2,464,285 founder shares to the Sponsor through share capitalization. As a result, the Sponsor holds an aggregate of 14,785,714 founder shares. All share and per share amounts have been retroactively presented (see Note 5).